Fed. Circ. Affirms Most Of $76M AstraZeneca Prilosec IP Win
The Federal Circuit on Tuesday left intact most of a $76 million damages award that Apotex Corp. was ordered to pay AstraZeneca AB for infringing two patents for the indigestion drug...To view the full article, register now.
Already a subscriber? Click here to view full article